FDA cleared Biolinq Shine, an over-the-counter glucose monitor with no needles (not even micro ones). It sits on the forearm, uses tiny semiconductor sensors just under the skin's surface, and shows your glucose range with a colored light, no phone required. It also tracks activity and sleep. It's cleared for adults 22 and older who don't use insulin, for general awareness, not dosing.

"Future of healthcare" pundits often suggest AI care will become cheap and ubiquitous, but the wealthy will pay extra for human care. But a survey of 4,000+ Japanese adults aged 55–75 points the other way: 65% would choose a nursing home where robots handle a big share of one part of care (lifting, monitoring, or conversation) over an all-human home, and they'd pay ~8% more. Robots even won for conversation/companionship: 59% to 41%. It may be possible that for many older people, the robot means more independence (from humans). America ≠ Japan, in so many ways. But maybe Americans (59% didn't want a robot caregiver in a 2017 Pew survey) will warm up once they start seeing this tech? buff.ly/qmo5iZ1 #DrYou #LongTermCare #aging h/t @margrev